Astellas Pharma
Search results
Jun 28, 2024 · Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
Our vision is to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. This purpose-led and values-based approach is a core foundation of our global growth strategy and long-term value creation for our stakeholders. Learn more.
Takeda's diverse therapeutic portfolio addresses gastrointestinal disorders, rare diseases, immunology, oncology, and vaccines (in pipeline), underscoring its commitment to data-driven innovation and transformative treatments. For more information, please review our full corporate presentation here.
Overview. Financial Highlights. Quarterly Results. Stock Information & Shareholder Returns. Securities Report & Form 20-F. IR Events. We bring our values to life through actions based on Patient-Trust-Reputation-Business, in that order.
The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical company.
Mar 31, 2022 · Information on the corporate headquarters of Takeda Pharmaceutical Company Limited, Japan office locations, and key facts about the company.
Zydus Takeda Healthcare Private Limited is a Joint Venture Company between two pharmaceutical giants Zydus Healthcare Limited; an India based leading Pharma Company with global footprints and Takeda Pharmaceuticals, the largest Pharmaceutical Company coming from Japan with worldwide presence.
May 11, 2022 · Leveraging its development strength, robust partnerships and innovative research engine, Takeda is focused on providing transformative treatments for targeted populations with high unmet needs across its core therapeutic areas.
Jul 30, 2020 · Christophe Weber, the CEO of Takeda Pharmaceuticals, has been solving for the tectonic changes brought on by COVID-19 by centering on his company’s nearly 240-year-old value system, and on connecting outward—across borders, regions, and continents.
Guided by our vision to discover and deliver life-transforming treatments, and with a focus on maintaining solid investment grade credit ratings, we will allocate capital to deliver sustainable value to patients and attractive returns to our shareholders. Takeda's policy in the allocation of capital is as follows.
